SCM
GH icon

Silverarc Capital Management’s Guardant Health GH Stock Holding History

Silverarc Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.1M Buy
98,514
+6,600
+7% +$663K 1.07% 29
2025
Q4 		$9.39M Buy
+91,914
New +$8.22M 1.36% 26
2021
Q4 		– Sell
-4,218
Closed -$527K – 81
2021
Q3 		$527K Sell
4,218
-455
-10% -$54.1K 0.31% 66
2021
Q2 		$580 Sell
4,673
-5,519
-54% -$742K 0.28% 77
2021
Q1 		$1.56M Sell
10,192
-8,633
-46% -$1.3M 0.87% 44
2020
Q4 		$2.43M Buy
+18,825
New +$2.17M 1.48% 26

Other funds holding GH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return